4D Molecular Therapeutics, Inc.
FDMT
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 85.2 | 85.2 | 0.0 | 20.7 | 3.1 | 18.0 | 13.6 | 7.0 | 14.1 | 5.8 | |
| Cost of Revenues | 97.2 | 7.6 | 0.0 | 97.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -12.0 | 77.6 | 0.0 | -76.4 | 3.1 | 18.0 | 13.6 | 7.0 | 14.1 | 5.8 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 85.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.2 | |
| Cost of Revenues | 2.0 | 47.2 | 48.0 | 0.0 | 1.8 | 0.0 | 31.9 | 27.9 | 4.2 | 1.4 | |
| Gross Profit | 83.1 | -47.1 | -47.9 | 0.0 | -1.8 | 0.0 | -31.9 | -27.8 | -4.3 | 18.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 97.1 | 80.3 | 61.4 | 53.0 | 38.7 | 18.4 | 13.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 36.5 | 32.9 | 28.0 | 17.2 | 13.9 | 6.2 | 3.5 | |
| Depreciation & Amortization | 0.0 | 7.6 | 6.7 | 5.7 | 3.9 | 3.0 | 1.4 | 11.3 | 0.7 | 0.6 | |
| Total Operating Expenses | 147.6 | 237.1 | 187.9 | 133.6 | 113.2 | 89.4 | 70.3 | 52.6 | 24.5 | 17.1 | |
| Operating Income | -159.5 | -159.5 | -187.8 | -112.9 | -110.0 | -71.3 | -56.7 | -50.8 | -10.4 | -11.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.0 | 25.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.6 | 9.1 | ||
| Depreciation & Amortization | -4.2 | 1.3 | 1.2 | 1.8 | -4.9 | 1.7 | 1.2 | 1.2 | 1.5 | 1.4 | ||
| Total Operating Expenses | 68.4 | 14.0 | 11.5 | 53.6 | 54.3 | 51.1 | 10.6 | 10.3 | 36.6 | 34.2 | ||
| Operating Income | 14.7 | -61.2 | -59.5 | -53.6 | -56.1 | -51.1 | -42.5 | -38.1 | -36.7 | -14.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 19.5 | 19.5 | 27.1 | 12.2 | 2.6 | 0.1 | 0.2 | 1.5 | 0.9 | 0.1 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -6.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 19.4 | 19.4 | 27.0 | 12.0 | 2.5 | 0.0 | 0.0 | 1.5 | 0.0 | 0.0 | |
| IBT | -140.1 | -140.1 | -160.9 | -100.8 | -107.5 | -71.3 | -56.7 | -49.3 | -9.6 | -11.2 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -6.4 | -3.0 | -0.2 | 3.6 | 0.8 | -0.1 | |
| Net Income | -140.1 | -140.1 | -160.9 | -100.8 | -101.1 | -68.3 | -56.5 | -52.9 | -9.6 | -11.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.7 | 4.3 | 4.9 | 5.6 | 6.5 | 7.3 | 7.5 | 5.7 | 4.4 | 3.9 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 0.0 | ||
| Other Expense | 4.7 | 4.3 | 4.8 | 5.6 | 6.4 | 7.3 | 7.5 | 5.7 | 4.4 | 3.7 | ||
| IBT | 19.4 | -56.9 | -54.7 | -48.0 | -49.7 | -43.8 | -35.0 | -32.4 | -32.3 | -10.3 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.7 | -3.9 | ||
| Net Income | 19.4 | -56.9 | -54.7 | -48.0 | -49.7 | -43.8 | -35.0 | -32.4 | -32.3 | -10.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.58 | $-3.12 | $-2.46 | $-8.79 | $-3.57 | $-0.76 | $-0.76 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.58 | $-3.12 | $-2.46 | $-8.79 | $-3.57 | $-0.76 | $-0.76 | |
| Shares Outstanding | 57.9 | 57.9 | 53.9 | 39.1 | 32.4 | 27.7 | 6.4 | 14.8 | 12.5 | 14.8 | |
| Diluted Shares Outstanding | 57.9 | 57.9 | 53.9 | 39.1 | 32.4 | 27.7 | 6.4 | 14.8 | 12.5 | 14.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.83 | $-0.24 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.83 | $-0.24 | ||
| Shares Outstanding | 57.9 | 56.1 | 55.9 | 55.7 | 53.9 | 55.6 | 55.3 | 49.3 | 39.1 | 42.3 | ||
| Diluted Shares Outstanding | 57.9 | 56.1 | 55.9 | 55.7 | 53.9 | 55.6 | 55.3 | 49.3 | 39.1 | 42.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 189.1 | 149.3 | 249.1 | 218.6 | 315.4 | 276.7 | 49.7 | 91.8 | 23.9 | |
| Short Term Investments | 352.9 | 275.5 | 39.1 | 161.2 | 94.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 541.9 | 424.9 | 288.2 | 218.6 | 315.4 | 276.7 | 49.7 | 91.8 | 23.9 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 | 1.0 | 1.1 | 0.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | -8.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 10.7 | 10.1 | 8.4 | 7.0 | 8.5 | 4.4 | 0.0 | 1.2 | 0.3 | |
| Total Current Assets | 552.6 | 434.9 | 296.6 | 220.5 | 315.4 | 282.7 | 52.5 | 94.1 | 24.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 48.6 | 77.2 | 133.5 | 149.3 | 187.5 | 189.1 | 275.6 | 249.1 | 275.7 | 310.3 | |
| Short Term Investments | 256.5 | 216.1 | 187.9 | 275.5 | 314.4 | 352.9 | 250.3 | 39.1 | 44.0 | 74.0 | |
| Total Cash & ST Investments | 305.1 | 293.2 | 321.4 | 424.9 | 501.9 | 541.9 | 525.9 | 288.2 | 319.7 | 310.3 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 7.3 | 10.1 | 11.1 | 10.1 | 8.9 | 10.7 | 9.7 | 8.4 | 8.6 | 7.4 | |
| Total Current Assets | 312.4 | 303.3 | 332.6 | 434.9 | 510.8 | 552.6 | 535.6 | 296.6 | 328.2 | 310.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 29.4 | 40.6 | 31.7 | 35.3 | 29.0 | 5.1 | 5.0 | 2.5 | 2.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 35.7 | 80.6 | 11.0 | 4.9 | 67.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.3 | 4.3 | 0.7 | 1.1 | -58.5 | 0.6 | 0.7 | 0.4 | 0.1 | |
| Total Long-Term Assets | 67.5 | 125.5 | 43.3 | 41.3 | 38.1 | 5.7 | 5.7 | 2.9 | 2.8 | |
| Total Assets | 620.1 | 560.4 | 339.9 | 261.8 | 353.5 | 288.3 | 58.2 | 97.0 | 27.3 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 35.1 | 37.2 | 39.1 | 40.6 | 41.6 | 29.4 | 30.6 | 31.7 | 32.7 | 33.6 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 67.2 | 123.8 | 137.0 | 80.6 | 48.8 | 35.7 | 62.9 | 11.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 9.4 | 9.4 | 7.0 | 4.3 | 2.9 | 2.3 | 0.8 | 0.7 | 0.7 | 8.5 | |
| Total Long-Term Assets | 111.6 | 170.4 | 183.2 | 125.5 | 93.3 | 67.5 | 94.3 | 43.3 | 33.4 | 42.2 | |
| Total Assets | 424.0 | 473.6 | 515.7 | 560.4 | 604.0 | 620.1 | 629.9 | 339.9 | 361.6 | 352.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.4 | 4.4 | 3.5 | 3.3 | 4.8 | 1.8 | 1.7 | 1.0 | 0.5 | |
| Short-Term Debt | 3.2 | 5.6 | 6.3 | 2.7 | 1.2 | 0.0 | 0.0 | 0.1 | 0.1 | |
| Other Current Liabilities | 11.5 | 18.9 | 8.9 | 8.9 | 7.7 | 8.4 | 5.3 | 2.1 | 1.0 | |
| Current Liabilities | 19.4 | 29.1 | 19.0 | 15.7 | 16.3 | 16.7 | 13.0 | 8.1 | 5.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.9 | 8.7 | 4.2 | 4.4 | 2.9 | 3.4 | 4.2 | 3.5 | 4.7 | 3.5 | |
| Short-Term Debt | 5.7 | 5.7 | 5.7 | 5.6 | 5.1 | 3.2 | 3.2 | 3.1 | 6.3 | 6.2 | |
| Other Current Liabilities | 24.2 | 19.2 | 16.2 | 18.9 | 21.4 | 12.8 | 9.0 | 12.0 | 7.9 | 3.0 | |
| Current Liabilities | 37.1 | 34.7 | 26.9 | 29.1 | 29.5 | 19.4 | 16.4 | 19.0 | 18.2 | 13.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 10.5 | 19.0 | 11.5 | 13.5 | 15.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 10.5 | 24.6 | 14.7 | 16.1 | 16.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 31.8 | 49.8 | 32.1 | 30.5 | 560.5 | 31.9 | 131.2 | 124.6 | 46.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 16.6 | 17.4 | 18.2 | 19.0 | 19.7 | 10.5 | 11.0 | 11.5 | 12.0 | 12.5 | |
| Capital Leases | 22.3 | 23.1 | 23.9 | 24.6 | 24.8 | 13.7 | 14.2 | 14.7 | 15.2 | 15.6 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | 0.2 | |
| Total Liabilities | 55.0 | 52.7 | 46.0 | 49.8 | 51.1 | 31.8 | 29.3 | 32.1 | 31.7 | 725.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -482.7 | -576.2 | -415.3 | -314.5 | -207.0 | -135.7 | -79.0 | -30.0 | -20.5 | |
| Comprehensive Income | -0.3 | 0.2 | 0.0 | -1.2 | -0.4 | -288.3 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 588.3 | 510.6 | 307.8 | -314.5 | -207.0 | 256.4 | -73.0 | -27.6 | -19.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -735.7 | -678.8 | -624.2 | -576.2 | -526.5 | -482.7 | -447.7 | -415.3 | -383.0 | -372.8 | |
| Comprehensive Income | 0.7 | 0.3 | 0.3 | 0.2 | 1.1 | -0.3 | -0.1 | 0.0 | 0.5 | 0.3 | |
| Total Common Equity | 369.0 | 420.9 | 469.7 | 510.6 | 552.9 | 588.3 | 600.6 | 307.8 | 329.9 | -372.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 13.7 | 24.6 | 14.7 | 16.1 | 16.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 588.3 | 510.6 | 307.8 | 231.3 | -207.0 | 256.4 | -73.0 | -27.6 | -19.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 369.0 | 420.9 | 469.7 | 510.6 | 552.9 | 588.3 | 600.6 | 307.8 | 329.9 | -372.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -109.9 | -140.1 | -160.9 | -100.8 | -107.5 | -71.3 | -56.7 | -49.3 | -9.6 | -11.2 | |
| Depreciation & Amortization | 6.1 | 7.6 | 6.7 | 5.7 | 3.9 | 3.0 | 1.4 | 1.0 | 0.7 | 0.6 | |
| Stock-Based Compensation | 22.5 | 22.0 | 26.1 | 19.7 | 17.1 | 13.8 | 5.0 | 3.5 | 1.4 | 0.3 | |
| Change Working Capital | -0.4 | 6.2 | 0.5 | 0.6 | -1.3 | -15.5 | -0.7 | 0.3 | -8.8 | 18.5 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | -0.5 | 0.1 | -0.8 | -0.3 | |
| Change In Accounts Payable | 0.2 | 6.8 | 0.9 | 0.9 | -1.6 | 2.3 | 0.0 | 0.5 | 0.4 | -0.1 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.5 | -0.6 | 2.9 | 0.2 | -0.1 | |
| Other Non-cash Items | 15.7 | -4.8 | -7.1 | -1.0 | 1.1 | 0.9 | 0.0 | 5.1 | 0.0 | 0.0 | |
| Cash from Operations | -85.2 | 0.0 | 0.0 | -75.8 | -86.7 | -69.1 | -50.9 | -36.7 | -16.3 | 8.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 19.4 | -56.9 | -54.7 | -48.0 | -49.7 | -43.8 | -35.0 | -32.4 | -32.3 | -10.3 | |
| Depreciation & Amortization | 2.0 | 2.0 | 1.9 | 1.8 | 1.8 | 1.7 | 1.6 | 1.6 | 1.5 | 1.4 | |
| Stock-Based Compensation | 5.6 | 4.5 | 5.0 | 7.0 | 0.0 | 6.5 | 6.1 | 6.0 | 5.9 | 4.6 | |
| Change Working Capital | 2.8 | 5.0 | 5.6 | -7.2 | -3.7 | 8.5 | -0.7 | -3.5 | 0.7 | 3.1 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 4.3 | -1.8 | 4.5 | -0.2 | 1.5 | -0.5 | -0.8 | 0.7 | -1.1 | 1.4 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -1.1 | -1.1 | -1.2 | -1.4 | 5.7 | -2.2 | -2.3 | -0.7 | 0.2 | 0.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -24.7 | -1.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.0 | -0.5 | -3.8 | -2.8 | -11.5 | -9.1 | -1.0 | -3.2 | -0.4 | -0.6 | |
| Acquisitions | 49.1 | 0.0 | 0.0 | 0.0 | 11.5 | 9.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -408.7 | -442.8 | -467.7 | -54.8 | -153.3 | -168.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 97.2 | 350.4 | 169.0 | 173.3 | 147.8 | 5.0 | 0.0 | 0.0 | 0.0 | 8.2 | |
| Other Investing Activities | -19.4 | 0.0 | 0.0 | 0.0 | -11.5 | -9.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -313.5 | 0.0 | 0.0 | 115.7 | -17.1 | -172.7 | -1.0 | -3.2 | -0.4 | 7.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.7 | 0.1 | -0.1 | -0.6 | -0.9 | -1.8 | -0.3 | -0.7 | -0.5 | -0.4 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 49.1 | 0.0 | |
| Investments | -178.1 | -15.2 | -115.4 | -134.1 | -57.8 | -35.8 | -96.8 | -277.3 | -34.6 | 0.0 | |
| Sales of Investment | 49.2 | 32.9 | 101.6 | 166.7 | 65.8 | 64.9 | 23.6 | 14.8 | 28.5 | 30.4 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -49.1 | 30.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.7 | 30.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -2.0 | 24.6 | 9.9 | -1.5 | -0.3 | 16.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 345.1 | 0.0 | 0.0 | 148.3 | 2.7 | 114.3 | 205.7 | 0.1 | 0.1 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 9.5 | 0.0 | 0.0 | 8.5 | 0.4 | 3.8 | 73.3 | -2.3 | 84.5 | 0.0 | |
| Cash from Financing | 351.4 | 0.0 | 0.0 | 156.8 | 3.1 | 118.1 | 279.0 | -2.2 | 84.6 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 22.3 | -0.8 | -0.8 | -0.8 | -0.2 | 11.2 | -0.5 | -0.5 | -0.5 | -0.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.8 | 1.6 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.8 | 10.6 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -73.8 | -89.1 | -99.8 | 196.8 | -100.7 | -123.7 | 227.1 | -42.1 | 67.9 | 15.9 | |
| Closing Cash Balance | 189.1 | 60.2 | 149.3 | 249.1 | 52.4 | 153.0 | 276.7 | 49.7 | 91.8 | 23.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 11.7 | -28.6 | -63.8 | -15.8 | -38.2 | -1.5 | -86.5 | 26.5 | -26.6 | 39.4 | |
| Closing Cash Balance | 60.2 | 48.6 | 69.7 | 133.5 | 149.3 | 187.5 | 189.1 | 275.6 | 249.1 | 275.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -87.2 | -109.1 | -138.4 | -78.6 | -98.2 | -78.2 | -51.9 | -39.9 | -16.7 | 7.7 | |
| Real Free Cash Flow | -109.7 | -131.1 | -164.5 | -98.2 | -115.3 | -92.0 | -56.9 | -43.5 | -18.0 | 7.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 27.9 | -46.4 | -43.4 | -48.4 | -46.8 | -31.2 | -30.6 | -29.8 | -25.2 | -1.6 | |
| Real Free Cash Flow | 22.4 | -50.9 | -48.4 | -55.4 | -46.8 | -37.7 | -36.7 | -35.8 | -31.1 | -6.1 |
